Previous studies have demonstrated high LRH-1 expression in various cancer cells and tissues and provided supporting evidence of the oncogenic roles of LRH-1 (Lin et al., 2014a; Nadolny and Dong, 2015; Liu et al., 2018; Wu et al., 2018). Here, NR5A2 is linked to cancer.